You searched for "IRD"
Anatomical and functional outcomes following switching from aflibercept to ranibizumab in NARMD
5 June 2020
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is a six-month, prospective, single-arm study in the UK and Germany. A total of 100 patients were enrolled (one in the primary failure group, 99 in the suboptimal treatment response group), treated three-monthly intravitreal ranibizumab injections (0.5mg), and then...
Charles Bonnet Syndrome emerges from the shadows
10 November 2020
There has been a ground-breaking response to the online Charles Bonnet Syndrome Patient Information event on
16 November.
Factors associated with seeking delayed strabismus surgery
The purpose of this study was to investigate the main reasons for delay in strabismus surgery and assess patients’ motivations to undergo strabismus surgery in adulthood. This was a prospective study in the Republic of Moldova of 91 patients with...UKNOS (UK Neuro-ophthalmology Society) Annual Meeting 2024
8 February 2024
UKNOS 2023 sold out so book here now at early bird rates to avoid disappointment & save on cost Newcastle will host our next annual meeting on Feb 8th 2024, focused on Managing Uncertainty(ies) in Neuro-Ophthalmology - join us and...
OCT prognostic factors in AMD patients with peripapillary choroidal neovascularisation
3 August 2023
| Sofia Rokerya
|
EYE - Vitreo-Retinal
In this retrospective study the authors aimed to investigate the correlation between optical coherence tomography (OCT) findings and visual acuity outcomes after treatment with intravitreal bevacizumab (IVB) injections for age-related macular degeneration (AMD) patients with peripapillary choroidal neovascularisation (PPCNV). Data...
Impact of COVID-19 on primary retinal detachments
3 October 2022
| Sofia Rokerya
|
EYE - Vitreo-Retinal, EYE - General
|
Coronavirus disease 19, Primary retinal detachment, Vitrectomy
This study aimed to describe the impact of the COVID-19 pandemic on the presentation characteristics, timings, and surgical decisions for primary rhegmatogenous retinal detachment (RRD). The cohort included all patients who presented to a Portuguese centre over a two-year period,...
Chandelier-assisted versus standard scleral buckling for rhegmatogenous retinal detachment repair. Systematic review and meta-analysis
4 December 2024
| Sofia Rokerya
|
EYE - Vitreo-Retinal
Despite a significant global decline in standard scleral buckling (SSB) procedures for rhegmatogenous retinal detachment (RRD), it continues to hold its place as an essential treatment option, offering distinct advantages such as cost-effectiveness, preservation of the vitreous, improved final visual...
UK Eye Genetics Group Annual Conference
9 June 2023
by Chloe M. Stanton, UK-EGG Treasurer, MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh Delegates including ophthalmic clinicians, clinical geneticists, genetic counsellors and research scientists travelled to Edinburgh from across the UK and Europe to attend...
Ocular complications in retinal vasculitis
1 February 2018
| Efrosini Papagiannuli
|
EYE - Vitreo-Retinal
In this retrospective study the authors aimed to characterise the incidence rates of visual loss and ocular complications associated with retinal vasculitis (RV – annual incidence of 1-2/ 100000/ per annum). A secondary objective was to compare the visual outcomes...
Sight Sciences OMNI® Masterclass, Colchester
23 January 2023
|
Awards, Conferences & Anniversaries
Saturday 14th January saw Sight Sciences hold their third UK Masterclass for the OMNI Surgical System.
Ocular toxoplasmosis
3 June 2021
| Jonathan Chan
|
EYE - Vitreo-Retinal
|
acute chronic infection, ocular toxoplasmosis, serology IgG IgM
This is a retrospective study of 106 patients between March 2011 and June 2018, of 37 IgM + group and 69 IgM - group of patients. The clinical features, demographics of patients with ocular toxoplasmosis (OT) were studied according to...
Uveitis ocular toxoplasmosis
1 October 2021
| Jonathan Chan
|
EYE - Vitreo-Retinal
This is a retrospective study of 106 patients between March 2011 and June 2018, of 37 IgM +group and 69 IgM - group of patients. The clinical features, demographics of patients with ocular toxoplasmosis (OT) were studied according to the...